Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Astex Pharmaceuticals, Inc. (ASTX) Starts Presentation at 25th Annual ROTH Conference

Astex Pharmaceuticals is a pharmaceutical company focused on the discovery and development of novel small molecule therapeutics, with a focus on oncology. The company is currently engaged in developing a proprietary pipeline of novel therapies and is creating de-risked products for partnership with leading pharmaceutical companies. The company developed Dacogen (decitabine) for injection and receives significant royalties for its worldwide sales. For more information, visit the company’s Web site: http://www.astx.com

Let us hear your thoughts below:

This year's annual ROTH Conference will take place at The Ritz Carlton located in Laguna Niguel, on March 17-12, 2013. Bringing together executives from more than 400 growth companies, the ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com.
This entry was posted in ROTH Capital Partners Conference. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *